Catalent Doubles Footprint of Oral Solid Dose Facility

Published on: 

Catalent completes a $52 million expansion program for advanced oral solid manufacturing solutions at its Winchester, KY, facility.


Catalent Pharma Solutions, a unit of Catalent, Inc., has announced the April 15 opening of an expansion at its Winchester, KY, manufacturing facility, which doubled the footprint to 180,000 sq. ft. The expansion features newly installed fluid bed capacity, expanded analytical laboratories, and an advanced, open facility design that provides flexibility in supporting the requirements of new customer programs.

The expansion was completed in response to increased customer demand for the manufacture of complex, oral solid formulations, as reported in a company press statement. The Winchester facility has more than 20 years of experience in product development, technology transfer, and commercial manufacturing. The site has produced over 3 billion tablets and capsules annually and launched more than 100 new products into the market since its inception.


Construction work on the expansion began in 2013 with a $35 million facility investment, followed by a subsequent investment in additional fluid bed capacity. The expansion will add as many as 140 new employees at the site, with potential to add further employees.

Source: Catalent Pharma Solutions